Research ArticleType 2 Diabetes

Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist

See allHide authors and affiliations

Science Translational Medicine  08 Oct 2014:
Vol. 6, Issue 257, pp. 257ra139
DOI: 10.1126/scitranslmed.3009934

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article